Kidney International
Media & Internet · New Jersey, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
340 North Ave E Ste 3, Cranford, New Jer...Phone Number
(888) 834-7287Website
www.kidney-international.orgRevenue
$20.1 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Kidney International
In this new educational series, we will address the broad area of data analyses in nephrology and transplantation using novel statistical approaches, machine learning and data mining, prediction modelling, data reduction techniques and development of novel trial ideas and application that are relevant to real world problems. Check out the statistics series here ! The power of big science, large consortia, and machine learning to create breakthroughs in disease management has been most prominently applied to the field of oncology, but these same tools can be applied to nephrology. Kidney International is proud to feature a collection of in-depth reviews on big science, artificial intelligence, and machine learning authored by world experts in the field. Check out the AI series here ! Check out the latest Controversies in Nephrology debate: Age- and gender-specific reference values of estimated GFR in Caucasians: The Nijmegen Biomedical Study Definition and classification of chronic kidnRead more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kidney International your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Kidney International has recently received funding, and reach out quickly before it becomes old news!
Click to see if Kidney International had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Kidney International is spiking on competitors!
Kidney International, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Kidney International launches new products
Earning: See what the market has to say on Kidney International recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Kidney International
Funding: Get notified immidiatlly once Kidney International has new funding data
Recommended Actions
Find VP level buyers at Kidney International
Find 3 more new buyers
Compare Similar Companies to Kidney International
Compare insights from companies similar to Kidney International, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Kidney International
$20.1M
51-200
Private
-
-
N/A
Company Profile Activity
Activity Insights
Kidney International is experiencing very low activity levels compared to other companies in the Media & Internet sector.
What does this means?
Kidney International is drawing exceptional interest within the Media & Internet industry, suggesting notable developments or strong market momentum, learn more about Kidney International.
Kidney International Tech Stack
A closer look at the technologies used by Kidney International
Kidney International News & Media
Poxel Announces Publication in Kidney International of PXL770 Preclinical Results in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
LYON, France--(BUSINESS WIRE)--Regulatory News: POXEL SA (Paris:POXEL) (Euronext: POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for serious chronic diseases with metabolic pathophysiology, including non-alcoholic steatohepatitis (NASH) and rare metabolic disorders, announced today the publication of preclinical results in autosomal dominant polycystic kidney disease (ADPKD) for PXL770, a novel, first-in-class direct adenosine monophosphate-acKidney International Publishes Results from NefIgArd Phase 3 Trial Evaluating TARPEYO[®] (budesonide) in IgA Nephropathy
Calliditas Therapeutics AB (Nasdaq: CALT, Nasdaq Stockholm: CALTX) (“Calliditas”) today announced Kidney International has published the successful results from NefIgArd Part A, their pivotal Phase 3, randomized, double-blind, placebo-controlled, multicenter study. The publication highlights the safety results and efficacy data related to both proteinuria and estimated glomerular filtration rate (eGFR) for patients treated with TARPEYO while on background of optimized and stable renin-angiotensi
Read more news
Top Media & Internet Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kidney International
Sign Up For FreeTo access detailed company insights
In this new educational series, we will address the broad area of data analyses in nephrology and transplantation using novel statistical approaches, machine learning and data mining, prediction modelling, data reduction techniques and development of novel trial ideas and application that are relevant to real world problems. Check out the statistic... Read More
